Facilitated By

San Antonio Medical Foundation

News

  • SystImmune, Inc. to Present Updated BL-B01D1 Data in Breast Cancer at SABCS Congress 2024

    (SystImmune), a clinical-stage biotechnology company, today announced ... San Antonio Breast Cancer Symposium (SABCS) 2024, taking place on ...

  • Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant ... - Quantisnow

    ... SAN ANTONIO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc ... Biotechnology: Biological Products (No Diagnostic Substances). Health Care ...

  • Wobble Genomics' technology demonstrates potential in accelerating precision medicine innovations

    Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, has presented new data at the San Antonio ...

  • Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...

    ... San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio ... Monte Rosa Therapeutics is a clinical-stage biotechnology company ...

  • Houston Medicine Magazine Headlines Powered By Business Wire

    Health | Biotechnology | Pharmaceutical ... View Press Release · BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio Breast ...